Inhibition of cell proliferation in human breast tumor cells by antisense oligonucleotides against facilitative glucose transporter 5

Journal of Cellular Biochemistry

Volumn 93, Issue 6, 2004, Pages 1134-1142

  Chan, K K ^a   Chan, Judy Y W ^a   Chung, Karen K W ^a   Fung, Kwok Pui ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Antisense; Breast tumor; Glucose transporter

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ESTROGEN RECEPTOR; GLUCOSE TRANSPORTER 5; TAMOXIFEN; FRUCTOSE; GLUCOSE TRANSPORTER; THYMIDINE;

AMINO ACID SEQUENCE; ARTICLE; BREAST CANCER; CANCER CELL; CANCER STAGING; CELL PROLIFERATION; CODON; DRUG EFFECT; HEPATOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; BREAST TUMOR; CELL CULTURE; DRUG ANTAGONISM; FEMALE; GENETICS; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; FEMALE; FRUCTOSE; GLUCOSE TRANSPORTER TYPE 5; HUMANS; LIVER NEOPLASMS; MONOSACCHARIDE TRANSPORT PROTEINS; OLIGONUCLEOTIDES, ANTISENSE; THYMIDINE; TUMOR CELLS, CULTURED;

EID: 21644463042     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20270     Document Type: Article

References (20)

1. Agrawal S, Zhao Q. 1998. Antisense therapeutics. Curr Opin Chem Biol 2:519-528.
2. Ahmed N, Berridge MV. 1998. Transforming oncogenes regulate glucose transport by increasing transporter affinity for glucose: Contrasting effects of oncogenes and heat stress in a murine marrow-derived cell line. Life Sci 63:1887-1903.
3. Chan JY, Chu AC, Fung KP. 2000. Inhibition of P-glycoprotein expression and reversal of drug resistance of human hepatoma HepG2 cells by multidrug resistance gene (mdr1) antisense RNA. Life Sci 67:2117-2124.
4. Chen CP, Li XX, Zhang LR, Min JM, Chan JY, Fung KP, Wang SQ, Zhang LH. 2002. Synthesis of antisense oligonucleotide-peptide conjugate targeting to GLUT-1 in HepG-2 and MCF-7 Cells. Bioconjug Chem 13:525-529.
5. Fingar DC, Birnbaum MJ. 1994. A role for Raf-1 in the divergent signaling pathways mediating insulin-stimulated glucose transport. J Biol Chem 269:10127-10132.
6. Fung KP, Choy YM, Chan TW, Lam WP, Lee CY. 1986. Glucose regulates its own transport in Ehrlich ascites tumour cells. Biochem Biophys Res Commun 134:1231-1237.
7. Giovine M, Gasparini A, Scarfi S, Damonte G, Sturla L, Millo E, Tonetti M, Benatti U. 1998. Synthesis and characterization of a specific peptide nucleic acid that inhibits expression of inducible NO synthase. FEBS Lett 426:33-36.
8. Grobholz R, Hacker HJ, Thorens B, Bannasch P. 1993. Reduction in the expression of glucose transporter protein GLUT 2 in preneoplastic and neoplastic hepatic lesions and re-expression of GLUT 1 in late stages of hepatocarcinogenesis. Cancer Res 53:4204-4211.
9. Haber RS, Rathan A, Weiser KR, Pritsker A, Itzkowitz SH, Bodian C, Slater G, Weiss A, Burstein DE. 1998. GLUT1 glucose transporter expression in colorectal carcinoma: A marker for poor prognosis. Cancer 83:34-40.
10. Kronenwett R, Haas R. 1998. Antisense strategies for the treatment of hematological malignancies and solid tumors. Ann Hematol 77:1-12.
11. Kurata T, Oguri T, Isobe T, Ishioka S, Yamakido M. 1999. Differential expression of facultative glucose transporter (GLUT) genes in primary lung cancers and their liver metastases. Jpn J Cancer Res 90:1238-1243.
12. Mercatante D, Kole R. 2000. Modification of alternative splicing pathways as a potential approach to chemotherapy. Pharmacol Ther 85:237-243.
13. Miayake H, Tolcher A, Gleave ME. 2000. Chemosensitizatioon and delayed androgen-independent recurrence of prostate cancer with the use of antisense Bcl-2 oligonucleotides. J Natl Cancer Inst 92:34-41.
14. Miyamoto K, Tatsumi S, Morimoto A, Minami H, Yamamoto H, Sone K, Taketani Y, Nakabou Y, Oka T, Takeda E. 1994. Characterization of the rabbit intestinal fructose transporter (GLUT5). Biochem J 303:877-883.
15. Noguchi Y, Saito A, Miyagi Y, Yamanaka S, Marat D, Doi C, Yoshikawa T, Tsuburaya A, Ito T, Satoh S. 2000. Suppression of facilitative glucose transporter 1 mRNA can suppress tumor growth. Cancer Lett 154:175-182.
16. White MK, Rail TB, Weber MJ. 1991. Differential regulation of glucose transporter isoforms by the src oncogene in chicken embryo fibroblasts. Mol Cell Biol 11:4448-4454.
17. Wood IS, Trayhurn P. 2003. Glucose transporters (GLUT and SGLT): Expanded families of sugar transport proteins. Br J Nutr 89:3-9.
18. Yamamoto T, Seino Y, Fukumoto H, Koh G, Yano H, Inagaki N, Yamada Y, Inoue K, Manabe T, Imura H. 1990. Over-expression of facultative glucose transporter genes in human cancer. Biochem Biophys Res Commun 170:223-230.
19. Younes M, Brown RW, Mody DR, Fernandez L, Laucirica R. 1995. GLUT1 expression in human breast carcinoma: Correlation with known prognostic markers. Anticancer Res 15:2895-2898.
20. Zamora-Leon SP, Golde DW, Concha II, Rivas CI, Delgado-Lopez F, Baselga J, Nualart F, Vera JC. 1996. Expression of the fructose transporter GLUT5 in human breast cancer. Proc Natl Acad Sci 93:1847-1852.